These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2338968)

  • 1. Differentiation of Charcot joint from osteomyelitis through dynamic bone imaging.
    Gandsman EJ; Deutsch SD; Kahn CB; McCullough RW
    Nucl Med Commun; 1990 Jan; 11(1):45-53. PubMed ID: 2338968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined leukocyte and bone imaging used to evaluate diabetic osteoarthropathy and osteomyelitis.
    Splittgerber GF; Spiegelhoff DR; Buggy BP
    Clin Nucl Med; 1989 Mar; 14(3):156-60. PubMed ID: 2736841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy.
    Palestro CJ; Mehta HH; Patel M; Freeman SJ; Harrington WN; Tomas MB; Marwin SE
    J Nucl Med; 1998 Feb; 39(2):346-50. PubMed ID: 9476948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of infected from noninfected rapidly progressive neuropathic osteoarthropathy.
    Miles K
    J Nucl Med; 1996 Apr; 37(4):706. PubMed ID: 8691271
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute Charcot foot changes versus osteomyelitis: does Tc-99m HMPAO labeled leukocytes scan differentiate?
    Boc SF; Brazzo K; Lavian D; Landino T
    J Am Podiatr Med Assoc; 2001; 91(7):365-8. PubMed ID: 11466463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of Charcot arthropathy and osteomyelitis.
    Soysal N; Ayhan M; Guney E; Akyol A
    Neuro Endocrinol Lett; 2007 Oct; 28(5):556-9. PubMed ID: 17994005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetic foot: Charcot joint and osteomyelitis.
    Giurato L; Uccioli L
    Nucl Med Commun; 2006 Sep; 27(9):745-9. PubMed ID: 16894330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.
    Oyen WJ; Netten PM; Lemmens JA; Claessens RA; Lutterman JA; van der Vliet JA; Goris RJ; van der Meer JW; Corstens FH
    J Nucl Med; 1992 Jul; 33(7):1330-6. PubMed ID: 1613574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evaluation of diabetic osteomyelitis: concise communication.
    Park HM; Wheat LJ; Siddiqui AR; Burt RW; Robb JA; Ransburg RC; Kernek CB
    J Nucl Med; 1982 Jul; 23(7):569-73. PubMed ID: 6211526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of differential scintigraphy in the clinical diagnosis of osseous and soft tissue changes affecting the diabetic foot.
    Visser HJ; Jacobs AM; Oloff L; Drago JJ
    J Foot Surg; 1984; 23(1):74-85. PubMed ID: 6230385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Imaging in Differentiating the Diabetic Charcot Foot from Osteomyelitis.
    Short DJ; Zgonis T
    Clin Podiatr Med Surg; 2017 Jan; 34(1):9-14. PubMed ID: 27865318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic bone imaging in the differential diagnosis of skeletal lesions.
    Gandsman EJ; McCullough RW
    Int J Rad Appl Instrum B; 1990; 17(6):533-41. PubMed ID: 2254091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-phase bone scintigraphy for diagnosis of Charcot neuropathic osteoarthropathy in the diabetic foot - does quantitative data improve diagnostic value?
    Fosbøl M; Reving S; Petersen EH; Rossing P; Lajer M; Zerahn B
    Clin Physiol Funct Imaging; 2017 Jan; 37(1):30-36. PubMed ID: 26147681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy.
    Seabold JE; Flickinger FW; Kao SC; Gleason TJ; Kahn D; Nepola JV; Marsh JL
    J Nucl Med; 1990 May; 31(5):549-56. PubMed ID: 2341891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging for infection: caution required with the Charcot joint.
    Knight D; Gray HW; McKillop JH; Bessent RG
    Eur J Nucl Med; 1988; 13(10):523-6. PubMed ID: 3371373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot.
    Unal SN; Birinci H; Baktiroğlu S; Cantez S
    Clin Nucl Med; 2001 Dec; 26(12):1016-21. PubMed ID: 11711704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging for differentiating osteomyelitis from acute neuropathic arthropathy in the complicated diabetic foot.
    Liao D; Xie L; Han Y; Du S; Wang H; Zeng C; Li Y
    Skeletal Radiol; 2018 Oct; 47(10):1337-1347. PubMed ID: 29654348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular Fixation in Charcot.
    Hutchinson B
    Clin Podiatr Med Surg; 2022 Oct; 39(4):643-658. PubMed ID: 36180194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced MR Imaging Techniques for Differentiation of Neuropathic Arthropathy and Osteomyelitis in the Diabetic Foot.
    Martín Noguerol T; Luna Alcalá A; Beltrán LS; Gómez Cabrera M; Broncano Cabrero J; Vilanova JC
    Radiographics; 2017; 37(4):1161-1180. PubMed ID: 28696850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of infected from noninfected rapidly progressive neuropathic osteoarthropathy.
    Schauwecker DS
    J Nucl Med; 1995 Aug; 36(8):1427-8. PubMed ID: 7629589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.